SCHEMBL23155208

SCHEMBL23155208

c1ccc2c(c1)-c1cccc3c1-c1cc(N(c4ccc5ccccc5c4)c4ccc5ccccc5c4)ccc1-c1cccc-3c1-2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ TSHR P16473 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ HSD17B1 P14061 1/20 0.33
▸ HSD17B2 P37059 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155182 0.95 ALDH1A1 (0.35) DNMT1ALDH1A1HSD17B10TSHRMAPK1
SCHEMBL23155214 0.91 HSD17B1 (0.38) DNMT1ALDH1A1HSD17B10TSHRTP53
SCHEMBL23155126 0.91 CYP1A2 (0.41) DNMT1L3MBTL1INSRIGF1RCYP2A6
SCHEMBL23155148 0.91 HSD17B1 (0.41) ALDH1A1TSHRHPGDHIF1AL3MBTL1
SCHEMBL23155247 0.90 HSD17B1 (0.44) ALDH1A1TSHRHPGDHIF1AL3MBTL1
SCHEMBL23155265 0.87 DNMT1 (0.38) DNMT1HDAC8CA1CA2ANPEP
SCHEMBL23155139 0.87 MAPT (0.37) DNMT1ALDH1A1TSHRHIF1AL3MBTL1
SCHEMBL23155372 0.87 HSD17B1 (0.41) TSHRHIF1AL3MBTL1ATMHSD17B1
SCHEMBL23155157 0.87 DNMT1 (0.40) DNMT1ALDH1A1HSD17B10TSHRMAPK1
SCHEMBL23155342 0.84 ALDH1A1 (0.42) ALDH1A1MAPK1L3MBTL1ATMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 DNMT1 1952/4885ALDH1A1 1348/4885HSD17B10 3005/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 DNMT1 1952/4885ALDH1A1 1348/4885HSD17B10 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback